Affimed N.V. announced the appointment of Ms. Uta Kemmerich-Keil as director on its Supervisory Board effective immediately. The appointment was approved during the Annual General Meeting of Shareholders on June 15, 2021. Ms. Kemmerich-Keil brings senior executive, finance and M&A expertise to Affimed and over 20 years of executive experience in the pharmaceutical and chemical industry. Most recently she led the international personal healthcare business of P&G and has over 19 years of experience at Merck KGaA, where she served, inter alia, as CEO of the global OTC- and global Allergy business, EVP Finance, Investor Relations and M&A.